Liquidia Corporation ( LQDA) - Stock Earnings
LQDA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 12, 2026 BeforeMarket | 0.74 / — | — | 171.7 million / — | — |
LQDA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 14.6 million USD | 92.0 million USD |
| 2026Q1 | 52.9 million USD | 132.9 million USD |
| 2026Q2 | 74.7 million USD | 171.7 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
LQDA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -78.5 million USD | 17.5 million USD |
| 2024 | -130.4 million USD | 14.0 million USD |
| 2025 | -68.9 million USD | 158.3 million USD |
| 2026 Est. | — | — |
LQDA
Price: $74.44
Earnings Per Share: 1.40 USD
P/E Ratio: 53.17
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 65756
Market Capitalization: 6.7 billion